Giuseppe Sconocchia

11PUBLICATIONS
47CO-AUTHORS
Medical infection agents (incl. prions)Gene and molecular therapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 28, 2025
Challenges in Multiple Myeloma Therapy in Older and Frail Patients.

Anna Aureli, Beatrice Marziani, Tommaso Sconocchia

|Jul 18, 2023
Impact of HLA Class I Antigen, Killer Inhibitory Receptor, and FCGR3A Genotypes on Breast Cancer Susceptibility and Tumor Stage.

Angelica Canossi, Anna Aureli, Tiziana Del Beato

|Jul 14, 2023
Acute Lymphoblastic Leukemia Immunotherapy Treatment: Now, Next, and Beyond.

Anna Aureli, Beatrice Marziani, Adriano Venditti

|Oct 14, 2022
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment.

Giuseppe Sconocchia, Giulia Lanzilli, Valeriana Cesarini

|Dec 24, 2021
Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia.

Anna Aureli, Beatrice Marziani, Tommaso Sconocchia

Pageof 2